Trial intelligence / Profile preview

Comparison of PRP, Microfat, and Combination for Knee Osteoarthritis

NCT06084637Phase 3Not yet recruiting

Sponsor
Assistance Publique-Hôpitaux de Marseille
Start
Feb 2024
Primary completion
Feb 2027
Modality
Adipose-derived MSCs, Bone Marrow MSCs
01

Overview

A Phase 3 trial of autologous microfat, platelet-rich plasma in osteoarthritis (OA), sponsored by Assistance Publique-Hôpitaux de Marseille. Planned start Feb 2024; status: not yet recruiting.

02

Drugs

autologous microfatplatelet-rich plasma
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT06084637.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06084637.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call